Highly convenient electrolysis procedure for the preparation of .alpha.-halogenated ketones and acetals from enol acetates, enol ethers, and silyl enol ethers
5,6,7-Trinor-4,8-inter-m-phenylene PGI derivatives and pharmaceutical compositions containing them
申请人:TORAY INDUSTRIES, INC.
公开号:EP0060640B1
公开(公告)日:1985-11-13
COMPOUNDS WITH MIXED PDE-INHIBITORY AND BETA-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
申请人:Artesian Therapeutics, Inc.
公开号:EP1565472A2
公开(公告)日:2005-08-24
US4564620A
申请人:——
公开号:US4564620A
公开(公告)日:1986-01-14
US4822804A
申请人:——
公开号:US4822804A
公开(公告)日:1989-04-18
[EN] COMPOUNDS WITH MIXED PDE-INHIBITORY AND beta-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE<br/>[FR] COMPOSES PRESENTANT UNE ACTIVITE MIXTE D'INHIBITION DE LA PDE ET D'ANTAGONISTE OU D'AGONISTE PARTIEL 20040617
申请人:ARTESIAN THERAPEUTICS INC
公开号:WO2004050657A2
公开(公告)日:2004-06-17
This invention provides compounds that possess inhibitory activity against β-adrenergic receptors and phosphodiesterase PDE, including phosphodiesterase 3 (PDE3 ). This invention further provides pharmaceutical compositions comprising such compounds; methods of using such compounds for treating cardiovascular disease, stroke, epilepsy, ophthalmic disorder or migraine; and methods of preparing pharmaceutical compositions and compounds that possess inhibitory activity against ß-adrenergic receptors and PDE.